¹û¶³´«Ã½

Vodafone: all eyes on cash generation and costs

Capex and cash flow considerations will be to the fore on results day

National Grid awaits regulatory determination

The power utility has maintained guidance for the full-year, but its medium-term prospects sit squarely with the regulator

Big pharma stymied by slump in non-Covid-19 treatments

The spread and duration of the pandemic is having a profound effect on the pharma industry, both in terms of performance and long-term strategic planning

Resurgent bitcoin still a wayward bet

Cryptocurrencies are finding their way onto corporate balance sheets, but it is hard to arrive at a justifiable investment angle

Wizz's counter-cyclical capacity build

The budget carrier is building to take advantage of post-pandemic opportunities

Bloomsbury beats expectations on consumer titles uplift

Sales have strengthened following the early disruption brought about by the pandemic

Fire and fury as Wetherspoons reports first loss in 36 years

The value pub chain believes it is being put at risk by a chaotic government response

British Land resumes dividends, but questions remain

The landlord has released some encouraging metrics, but the full impact of the disruption experienced through March/April may not yet be apparent

Volution still targeting margin expansion

The ventilation products supplier did not come through the lockdowns unscathed, but the regulatory dynamic underpinning the investment case remains in place

Renewi lifts expectations

The waste-to-products group has reacted swiftly to the challenges posed by the pandemic